ZURA
Zura Bio Limited · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +23.1% ·
aandelenstroom +7.4% ·
netto nieuwe posities +18.8%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 44 | +6 | 19.12M | $111.66M | +15 | −9 |
| Q1 2026 | 39 | +4 | 16.55M | $97.28M | +6 | −2 |
| Q4 2025 | 35 | -1 | 16.01M | $83.89M | — | −1 |
| Q3 2025 | 16 | +3 | 16.65M | $72.09M | +3 | — |
| Q2 2025 | 10 | -1 | 5.96M | $6.26M | — | −1 |
| Q1 2025 | 8 | -1 | 4.76M | $6.14M | +1 | −2 |
| Q4 2024 | 9 | 0 | 5.19M | $12.99M | +1 | −1 |
| Q3 2024 | 8 | +2 | 3.98M | $16.15M | +2 | — |
| Q2 2024 | 6 | — | 3.73M | $12.85M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | JPMorgan Chase ✦ | 9.25M | — | $40.05M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | JPMorgan Chase ✦ | 9.25M | — | $40.05M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | JPMorgan Chase ✦ | 9.25M | — | $40.05M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | JPMorgan Chase ✦ | 9.25M | — | $40.05M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Adage Capital Partners ✦ | 3.05M | Nieuw | $13.19M | 0.0% | New | 1 | SEC ↗ |
| 6 | Point72 Asset Management ✦ | 726.33K | -69.1% | $3.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 7 | Millennium Management ✦ | 589.70K | -25.3% | $2.55M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | Fidelity (FMR) ✦ | 531.29K | -6.7% | $2.30M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | The Vanguard Group ✦ (passief) | 517.14K | 0.0% | $2.24M | 0.0% | Held | 2 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passief) | 517.14K | 0.0% | $2.24M | 0.0% | Held | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passief) | 517.14K | 0.0% | $2.24M | 0.0% | Held | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passief) | 405.30K | -0.5% | $1.76M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passief) | 405.30K | -0.5% | $1.76M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 365.67K | -36.8% | $1.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 365.67K | -36.8% | $1.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 365.67K | -36.8% | $1.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Marshall Wace ✦ | 267.20K | Nieuw | $1.16M | 0.0% | New | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 267.20K | Nieuw | $1.16M | 0.0% | New | 1 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 255.40K | +25.1% | $1.11M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 209.43K | — | $906,814 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 209.43K | — | $906,814 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 209.43K | — | $906,814 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (passief) | 144.36K | 0.0% | $625,092 | 0.0% | Held | 4 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 136.30K | -44.4% | $590,192 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 25 | Goldman Sachs Group ✦ | 81.72K | — | $353,860 | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Goldman Sachs Group ✦ | 81.72K | — | $353,860 | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Citadel Advisors ✦ | 80.53K | Nieuw | $348,686 | 0.0% | New | 1 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 44.22K | -71.7% | $191,452 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 44.22K | -71.7% | $191,452 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 44.22K | -71.7% | $191,452 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 44.22K | -71.7% | $191,452 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Adage Capital Partners | $13.19M | 0.0% |
| Marshall Wace | $1.16M | 0.0% |
| Marshall Wace | $1.16M | 0.0% |
| Citadel Advisors | $348,686 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 92 houders, 61.32M aandelen, $364.31M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.